Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $131.14 million versus the consensus estimate of $131.87 million.

GUIDANCE:

Cellebrite DI Ltd. sees Q3 2026 revenue of $145-148 million, versus the consensus of $150.3 million.

Cellebrite DI Ltd. sees FY2026 revenue of $550-560 million, versus the consensus of $568 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.